For old or young dialysis patients, AV fistulas remain pure goldMarch 09, 2009A new study shows that for those individuals with chronic kidney disease, it doesn't matter if you're young or old: arteriovenous (AV) fistulas remain the gold standard for maintaining access to one's circulatory system to provide life-sustaining dialysis. Interventional radiologists found no difference between the two age groups when it comes to "patency" or the openness of AV fistulas or accesses needed for dialysis. Their results were presented at the Society of Interventional Radiology's 34th Annual Scientific Meeting. "Elderly patients' arteriovenous (AV) fistulas-vascular accesses needed for dialysis treatment-responded just as well as those in younger patients-in length of time the access stayed open and in moving blood flow efficiently. An AV fistula is the preferred access at any age," said Andrew R. Forauer, M.D., an interventional radiologist at Dartmouth-Hitchcock Medical Center in Lebanon, N.H. When kidneys fail-called chronic kidney or end-stage renal disease-treatment in the form of regular dialysis (or hemodialysis) is needed to replace the kidney's job of ridding the body of toxic waste products to maintain fluid, electrolyte and acid-base balance. A machine is used to filter blood outside one's body, allowing blood to flow, a few ounces at a time, through a special filter that removes wastes and extra fluids. The clean blood is then returned to a dialysis patient's body. Dialysis helps women and men feel better and live longer. "One of the greatest challenges facing patients and their doctors is keeping an individual's vascular access graft open for dialysis. AV fistulas remain the gold standard of access for kidney dialysis patients. They last longer, need less rework and are associated with lower rates of infections, hospitalization and death than other types of access," explained Forauer. A significant number of patients with chronic kidney failure receive dialysis using synthetic bridge grafts that tend to clot or malfunction, decreasing reliable access for life-sustaining dialysis and causing considerable morbidity, discomfort and inconvenience for dialysis patients, noted Forauer. "AV fistulas are underutilized in the United States yet they are best for keeping blood vessels open for access so individuals can continue to get their life-saving dialysis," said Forauer. Researchers studied how 72 patients (36 were 75 years or older) and 36 younger patients (between the ages of 40 and 60) would fare when comparing the patency of AV fistulas. Researchers collected information about the patients' other medical conditions-such as whether they had peripheral arterial disease (PAD) or diabetes, whether they were smokers and whether they used anticoagulant medications-to see how this information would play in the big picture. Elderly patients were more likely to be affected by these conditions; however, their comparison showed no difference in primary, primary assisted, secondary or postinterventional primary patency. "AV fistula patency after intervention does not differ between younger and older patient populations," said Forauer. Before dialysis can begin, a vascular access, which is the site on a patient's body where blood is removed and returned during dialysis, must be prepared. To maximize the amount of blood cleansed during dialysis treatments, the vascular access-such as an AV fistula-allows continuous high volumes of blood flow. An AV fistula is a connection created surgically by joining a vein and an artery in the forearm that allows blood from the artery to flow into the vein, thus providing access for dialysis. The increased blood flow makes the vein grow larger and stronger so it can be used for repeated needle insertions. This vascular access provides an efficient way for blood to be carried from one's body to the dialyzer and back without causing discomfort. Once matured, two needles are placed into the vein for dialysis. One needle is used to draw blood and run through the dialysis machine; the second needle returns the cleansed blood. Interventional radiologists monitor AV fistulas to avoid complications such as infection, blockage from clotting and poor blood flow. Interventional radiologists also keep AV fistulas or other accesses open or unclogged through minimally invasive techniques such as angioplasty or stenting. These interventions are safer, less costly and equally effective, and they improve the quality of life for dialysis patients. Nationally, there are an estimated 27 million people with chronic kidney disease, and nearly half a million are being treated for kidney failure, requiring dialysis or kidney transplant to live. More than 340,000 individuals receive dialysis treatments three times each week, according to national statistics. Over the past five years, the number of new patients with kidney failure has averaged more than 90,000 annually. Kidneys filter waste from the blood and regulate other functions of the body. Society of Interventional Radiology |
|||||||||||||||||||||
| Related Dialysis Current Events and Dialysis News Articles The cost of improving dialysis care Improving survival among dialysis patients may increase treatment costs significantly, according to a paper being presented at the American Society of Nephrology's 42nd Annual Meeting and Scientific Exposition in San Diego, CA. Women with chronic kidney disease more likely than men to go undiagnosed Woman are at particular risk of their primary care physicians delaying diagnosis of chronic kidney disease (CKD), according to a paper being presented at the American Society of Nephrology's 42nd Annual Meeting and Scientific Exposition in San Diego, California. For dialysis patients, skinny is dangerous Dialysis patients with low body fat are at increased risk of death-even compared to patients at the highest level of body fat percentage, according to research being presented at the American Society of Nephrology's 42nd Annual Meeting and Scientific Exposition in San Diego. Kidney transplants generally safe for lupus patients Individuals with a history of lupus who receive a kidney transplant rarely develop the serious inflammatory condition lupus nephritis in their new organ, according to a paper being presented at the American Society of Nephrology's 42nd Annual Meeting and Scientific Exposition in San Diego, CA. Muscle weakness a common side effect of long stays in intensive care units After decades of focusing on the management of respiratory failure, circulatory shock and severe infections that lead to extended stays in hospital intensive care units, critical care researchers are increasingly turning attention to what they believe is a treatable complication developed by many who spend days or weeks confined to an ICU bed: debilitating muscle weakness that can linger long after hospital discharge. Calculate benefit before dialysis for frail elders Kidney specialists should weigh the potential quality of life for frail elders with end-stage renal disease (ESRD) in opting for dialysis over more conservative therapies, a nephrologist and a palliative care specialist suggest in an editorial in the New England Journal of Medicine. Kidneys from deceased donors with acute renal failure expand donor pool Kidneys recovered from deceased donors with acute renal failure (ARF) - once deemed unusable for transplant - appear to work just as well as kidneys transplanted from deceased donors who do not develop kidney problems prior to organ donation. Few complications 1 year after aortic valve implantation Research presented at the 21st annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, sponsored by the Cardiovascular Research Foundation (CRF), demonstrated an "exceptionally low" rate of complications one year after implantation of transcatheter aortic valve prostheses. Link between depression, early stages of chronic kidney disease found by researchers One in five patients with chronic kidney disease is depressed, even before beginning long-term dialysis therapy or developing end-stage renal disease, UT Southwestern Medical Center researchers have found. Results from the Kyoto heart study The KYOTO HEART Study, which took place in Japan between January 2004 and January 2009, shows that the addition of valsartan to conventional antihypertensive treatment to improve blood pressure control is associated with an improved cardiovascular outcome in Japanese hypertensive patients at high risk of CVD events. More Dialysis Current Events and Dialysis News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||